Binding, presentation and immunogenicity of peptides derived from melanoma antigens MART-1 and GP100 by HLA-A2 subtypes

被引：0
|
作者：
Rivoltini, L
Loftus, DJ
Barracchini, K
Arienti, F
Mazzocchi, A
Squarcina, P
Biddison, WE
Appella, E
Parmiani, G
Marincola, FM
机构：
[1] NATL TUMOR INST MILAN,DIV EXPT ONCOL D,I-20133 MILAN,ITALY
[2] NCI,NIH,BETHESDA,MD 20892
来源：
FASEB JOURNAL | 1996年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：2706 / 2706
页数：1
相关论文
共 50 条
  • [1] Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes - Implications for peptide-based immunotherapy
    Rivoltini, L
    Loftus, DJ
    Barracchini, K
    Arienti, F
    Mazzocchi, A
    Biddison, WE
    Salgaller, ML
    Appella, E
    Parmiani, G
    Marincola, FM
    [J]. JOURNAL OF IMMUNOLOGY, 1996, 156 (10): : 3882 - 3891
  • [2] Laser scanning cytometry evaluation of MART-1, gp100, and HLA-A2 expression in melanoma metastases
    Mocellin, S
    Fetsch, T
    Abati, T
    Phan, GQ
    Wang, J
    Provenzano, M
    Stroncek, D
    Rosenberg, SA
    Marincola, FM
    [J]. JOURNAL OF IMMUNOTHERAPY, 2001, 24 (06): : 447 - 458
  • [3] DIFFERENTIAL EXPRESSION AND CTL RECOGNITION OF THE MELANOCYTIC-LINEAGE-ASSOCIATED ANTIGENS MART-1 AND GP100 COMPLEXED WITH HLA-A2 IN MELANOCYTES COMPARED TO MELANOMA-CELLS
    SALGALLER, ML
    POWDERLY, JW
    RIVOLTINI, L
    ROSENBERG, SA
    MARINCOLA, FM
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 1030 - 1030
  • [4] Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens
    Rosenberg, SA
    Zhai, YF
    Yang, JC
    Schwartzentruber, DJ
    Hwu, P
    Marincola, F
    Topalian, SL
    Restifo, NP
    Seipp, CA
    Einhorn, JH
    Roberts, B
    White, DE
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (24) : 1894 - 1900
  • [5] Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100
    Panelli, MC
    Wunderlich, J
    Jeffries, J
    Wang, E
    Mixon, A
    Rosenberg, SA
    Marincola, FM
    [J]. JOURNAL OF IMMUNOTHERAPY, 2000, 23 (04): : 487 - 498
  • [6] Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions
    Marincola, FM
    Hijazi, YM
    Fetsch, P
    Salgaller, ML
    Rivoltini, L
    Cormier, J
    Simonis, TB
    Duray, PH
    Herlyn, M
    Kawakami, Y
    Rosenberg, SA
    [J]. JOURNAL OF IMMUNOTHERAPY, 1996, 19 (03) : 192 - 205
  • [7] MART-1 and gp100 expressing and nonexpressing melanoma cells are equally proliferative in tumors and clonogenic in vitro
    Aris, Mariana
    Zubieta, Mariana Rodriguez
    Colombo, Marina
    Arriaga, Juan Martin
    Bianchini, Michele
    Alperovich, Myriam
    Bravo, Alicia Ines
    Barrio, Maria Marcela
    Mordoh, Jose
    [J]. CANCER RESEARCH, 2011, 71
  • [8] High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma
    TJ de Vries
    D Trančikova
    DJ Ruiter
    GNP van Muijen
    [J]. British Journal of Cancer, 1998, 78 : 1156 - 1161
  • [9] High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma
    de Vries, TJ
    Trancikova, D
    Ruiter, DJ
    van Muijen, GNP
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 (09) : 1156 - 1161
  • [10] Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients
    Xu, Yuanxin
    Theobald, Valerie
    Sung, Crystal
    DePalma, Kathleen
    Atwater, Laura
    Seiger, Keirsten
    Perricone, Michael A.
    Richards, Susan M.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2008, 6 (1)
12345